Key takeaways:
Entyvio (vedolizumab) is a biologic medication that treats moderate to severe Crohn’s disease and ulcerative colitis. It works by lowering inflammation in the GI tract.
Common Entyvio side effects include minor infection, headache, and joint pain. It can also cause more serious side effects, including rare cases of liver disease and severe infection.
Talk to your healthcare provider about the risks and benefits of Entyvio. Your provider can recommend different ways to keep you safe while receiving Entyvio, such as staying up-to-date with your vaccines.
Millions of U.S. adults live, work with, and manage inflammatory bowel disease (IBD) every day. IBD is a term that mainly describes two inflammatory gastrointestinal (GI) conditions: Crohn’s disease (CD) and ulcerative colitis (UC).
It’s unclear what the exact cause of IBD is. But it’s thought to be due to the immune system overreacting to triggers along the GI tract — causing excess inflammation. This can lead to stiff abdominal pain and frequent diarrhea, among other symptoms. Medications are often required to help get these symptoms under control. But sometimes it takes some trial and error to find a medication that’s effective and tolerable for you.
In this article, we’ll talk about a specific medication used to treat IBD — Entyvio (vedolizumab). We’ll also highlight seven noteworthy Entyvio side effects and how to manage them.
Entyvio is FDA-approved to treat moderate to severe CD and UC. It’s a type of biologic medication. Biologics are complex medications that come from natural or living sources instead of chemicals. They’re often used to manage hard-to-treat health conditions.
Entyvio is given through a vein once every 8 weeks (2 months). It’s an IV infusion that’s usually given at a hospital, clinic, or infusion center. Each infusion takes about 30 minutes to complete.
Potentially. Some people consider Entyvio to be a high-risk medication, but this isn’t an official description. That’s because it may contribute to rare but serious effects among people who take it. Some of the top risks are highlighted below.
Good to know: Entyvio doesn’t have any boxed warnings. This is the most serious medication warning that the FDA can assign to a medication. It’s reserved for especially risky medications.
Entyvio treats IBD by lowering inflammation in the GI tract. It does this by calming your immune system. This helps improve IBD symptoms, but it can also put people at a higher risk of infection.
Fortunately, most infections aren’t serious. The most common type of infection reported is the common cold (nasopharyngitis). This is also the most common side effect of Entyvio overall. Roughly 1 out of every 8 people experienced nasopharyngitis in Entyvio’s initial studies. Other types of common infections include:
You can potentially manage some infections, like the common cold, by yourself. But for more serious infections, it is a good idea to reach out to your healthcare provider.
It’s relatively common to develop symptoms that resemble the common cold or flu while receiving Entyvio. These may or may not be tied to an infection.
Headache is one common complaint. In fact, more than 1 out of every 9 people experience a headache with Entyvio. Other flu-like symptoms that are possible include:
Nausea
Fever
Tiredness
Cough
If you’re feeling under the weather before your Entyvio infusion, make sure to let your healthcare provider know. They may want to delay your infusion until you feel better. In the meantime, they’ll likely recommend ways to manage cold or flu symptoms you’re experiencing.
In Entyvio’s initial studies, about 12% of people reported feeling pain in their joints. Some people also had pain in their back, arms, and legs. However, these types of pain were less common.
The reason Entyvio may cause body pain is unclear. But joint pain is a known complication of IBD. This may be linked to the gut inflammation that people living with IBD experience. In fact, according to one study, the risk of joint pain from Entyvio is no higher than with other treatments, like TNF blockers.
Pain relievers like acetaminophen and NSAIDs like ibuprofen (Advil, Motrin) may be helpful in relieving headaches, back, and joint pain. Make sure to ask your healthcare provider if taking these medications would be appropriate.
Infusion reactions are possible with IV medications like Entyvio. They can occur any time you receive it; they can appear while you get the infusion or several hours afterwards. Infusion-related side effects can get worse for a couple days before they start to get better. Some of the most common symptoms are itching, redness, and swelling near the infusion site.
If you develop symptoms of an infusion reaction (or an allergic reaction) while you’re still receiving your infusion, make sure to alert your care team. They can manage the reaction by lowering how fast Entyvio is given. They may also give you medications to control pain or itching, like acetaminophen (Tylenol) or diphenhydramine (Benadryl).
If you’ve already left your treatment center, seek medical help if you experience hives, trouble breathing, or you feel like your heart is racing. This might be a sign of anaphylaxis, a serious allergic reaction.
If Entyvio causes an infection, it’s usually not that serious. But serious infections, such as tuberculosis (TB) and sepsis, can occur in rare cases. Your healthcare provider will likely test you for TB prior to starting Entyvio as a precaution.
In very rare cases, Entyvio can lead to a viral infection in the brain. This is called progressive multifocal leukoencephalopathy (PML). People who already have a weak immune system are at higher risk of PML.
For most people, the virus that causes this condition is nothing to worry about. It might not even cause symptoms. But for people with PML, the infection damages the coating that protects nerves in the brain. This can make it hard to control your body movements and it can cause memory problems. Ultimately, the infection can lead to severe disability and be life threatening.
Your healthcare provider will likely pause or stop your Entyvio treatment if you develop a severe infection of any type.
There are rare reports of people experiencing liver damage from Entyvio. It’s unclear why Entyvio does this.
Your healthcare provider may ask you to complete blood tests before and during treatment with Entyvio to monitor your liver health. They may also check to make sure you don’t have signs of hepatitis B infection. There’s a risk that Entyvio could worsen problems associated with this condition.
Inflammation of the pancreas, or pancreatitis, is another possible Entyvio side effect. Experts aren’t sure why it happens, but there have only been a handful of reports of pancreatitis in people who take it. This side effect can cause clammy skin, stomach pain, and difficulty eating.
Talk to your healthcare provider if you think you’re experiencing symptoms of pancreatitis. It’s important to manage pancreatitis quickly and try to prevent it from becoming a chronic issue.
Preventing infection should be top of mind while you’re taking Entyvio.
Some infections can be prevented by getting vaccinated. People should be up to date with their vaccines before starting Entyvio. People already getting Entyvio can get the yearly flu shot. But they should talk to their healthcare provider before considering the intranasal flu vaccine. This is because the nasal spray is a “live vaccine.” It contains a weakened form of the flu virus. People with weakened immune systems may be at higher risk for developing an infection after receiving a live vaccine.
Other common live vaccines you should avoid while receiving Entyvio include the following:
Measles, mumps, rubella (MMR II)
Varicella (Varivax) — the chickenpox vaccine
Yellow fever vaccine (YF-Vax)
Otherwise, your healthcare provider may give you medications — such as acetaminophen, diphenhydramine, or a corticosteroid — before your Entyvio infusions. These help prevent or lessen infusion reactions.
More serious side effects warrant medical advice in some capacity. It’s important to let your healthcare provider know if you develop signs or symptoms of a more serious infection. This includes:
A lasting fever
Chills
Shortness of breath
Sores on the skin
Pain while urinating
Allergic reactions from Entyvio can be life-threatening. Seek immediate medical attention if you notice signs of anaphylaxis during or after you receive your infusion. Symptoms may include:
Shortness of breath
Wheezing
Throat tightness
Hives
An irregular heartbeat
Common Entyvio side effects include mild to moderate infection, headache and other flu-like symptoms, and joint pain. In rare cases, Entyvio can cause severe, life-threatening infections, anaphylaxis, or liver problems. Before starting Entyvio, talk with your healthcare provider about the risks and benefits of this medication.
Cai, T., et al. (2018). The association Between arthralgia and vedolizumab using natural language processing. Inflammatory Bowel Diseases.
Card, T., et al. (2018). What is the risk of progressive multifocal leukoencephalopathy in patients with ulcerative colitis or Crohn's disease treated with vedolizumab?. Inflammatory bowel diseases.
Centers for Disease Control and Prevention. (2018). What is inflammatory bowel disease (IBD)?
Centers for Disease Control and Prevention. (2021). Live, intranasal influenza VIS.
Centers for Disease Control and Prevention. (2022). Prevalence of IBD.
Dreischulte, T., et al. (2012). High-risk prescribing and monitoring in primary care: How common is it, and how can it be improved?. Therapeutic Advances in Drug Safety.
Loftus, E. V., Jr., et al. (2020). Long-term safety of vedolizumab for inflammatory bowel disease. Alimentary Pharmacology & Therapeutics.
Massironi, S., et al. (2022). Systematic review — pancreatic involvement in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics.
MedlinePlus. (2022). Progressive multifocal leukoencephalopathy.
Takeda Pharmaceuticals U.S.A., Inc. (2022). Entyvio- vedolizumab injection, powder, lyophilized, for solution [package insert].
Takeda Pharmaceuticals U.S.A., Inc. (2022). Medication guide entyvio (vedolizumab) for injection, for intravenous use [package insert].
U.S. Food and Drug Administration. (2018). What are "biologics" questions and answers.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.